Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Central Sleep Apnea HELP
Based on 971 articles published since 2010

These are the 971 published articles about Sleep Apnea, Central that originated from Worldwide during 2010-2020.
+ Citations + Abstracts
Pages: 1 · 2 · 3 · 4 · 5 · 6 · 7 · 8 · 9 · 10 · 11 · 12 · 13 · 14 · 15 · 16 · 17 · 18 · 19 · 20
1 Guideline Australasian Sleep Association clinical practice guidelines for performing sleep studies in children. 2017

Pamula, Yvonne / Nixon, Gillian M / Edwards, Elizabeth / Teng, Arthur / Verginis, Nicole / Davey, Margot J / Waters, Karen / Suresh, Sadasivam / Twiss, Jacob / Tai, Andrew. ·Department of Respiratory and Sleep Medicine, Women's and Children's Hospital, North Adelaide, South Australia, Australia. Electronic address: yvonne.pamula@sa.gov.au. · The Ritchie Centre, Hudson Institute of Medical Research, Clayton, Victoria, Australia; Department of Paediatrics, Monash University, Clayton, Victoria, Australia; Melbourne Children's Sleep Centre, Monash Children's Hospital, Clayton, Victoria, Australia. · Paediatric Respiratory Department, Starship Children's Hospital, Auckland, New Zealand. · Department of Sleep Medicine, Sydney Children's Hospital, Randwick, New South Wales, Australia; School of Women's and Children's Health, Faculty of Medicine, University of New South Wales, Kensington, New South Wales, Australia. · Melbourne Children's Sleep Centre, Monash Children's Hospital, Clayton, Victoria, Australia. · Department of Respiratory Medicine, The Children's Hospital at Westmead, Westmead, New South Wales, Australia; Sydney Medical School, University of Sydney, Sydney, New South Wales, Australia. · Department of Respiratory and Sleep Medicine, Lady Cilento Children's Hospital, South Brisbane, Queensland, Australia. · Department of Respiratory and Sleep Medicine, Women's and Children's Hospital, North Adelaide, South Australia, Australia; Robinson Research Institute, University of Adelaide, Adelaide, South Australia, Australia. ·Sleep Med · Pubmed #28648225.

ABSTRACT: -- No abstract --

2 Guideline [Guidelines in Practice: The New S3 Guideline "Sleeping Disorders - Sleep-Related Abnormal Breathing"]. 2017

Gerlach, M / Sanner, B. ·Medizinische Klinik, Agaplesion Bethesda Krankenhaus Wuppertal. ·Pneumologie · Pubmed #28558398.

ABSTRACT: Sleep related breathing disorders include central sleep apnea (CSA), obstructive sleep apnea (OSA), sleep-related hypoventilation, and sleep-related hypoxia. These disorders are frequent and growing in clinical relevance. The related chapter of the S3 guideline "Non-restorative sleep/Sleep disorders", published by the German Sleep Society (DGSM), has recently been updated in November 2016. Epidemiology, diagnostics, therapeutic procedures, and classification of sleep related disorders have been revised. Concerning epidemiology, a considerably higher mortality rate among pregnant women with OSA has been emphasized. With regards to diagnostics, the authors point out that respiratory polygraphy may be sufficient in diagnosing OSA, if a typical clinical condition is given. For CSA, recommendations were changed to diagnose CSA with low apnea rates present. Significant changes for treating CSA in patients with left ventricular dysfunction have been introduced. In addition, there is now to be differentiated between sleep-related hypoventilation and sleep-related hypoxaemia. Obesity hypoventilation syndrome is discussed in more detail. This article sums up and comments on the published changes.

3 Guideline Implications of revised AASM rules on scoring apneic and hypopneic respiratory events in patients with heart failure with nocturnal Cheyne-Stokes respiration. 2015

Heinrich, Jessica / Spießhöfer, Jens / Bitter, Thomas / Horstkotte, Dieter / Oldenburg, Olaf. ·Department of Cardiology, Heart and Diabetes Centre North Rhine-Westphalia, Ruhr University Bochum, Bad Oeynhausen, Germany. ·Sleep Breath · Pubmed #24906544.

ABSTRACT: STUDY OBJECTIVES: This study investigated the implications of the revised scoring rules of the American Academy of Sleep Medicine (AASM) in patients with heart failure (HF) with Cheyne-Stokes respiration (CSR). METHODS: Ninety-one patients (NYHA ≥II, LVEF ≤45 %; age 73.6 ± 11.3 years old; 81 male subjects) with documented CSR underwent 8 h of cardiorespiratory polygraphy recordings. Those were analyzed by a single scorer strictly applying the 2007 recommended, 2007 alternative, and the 2012 scoring rules. RESULTS: Compared with the AASM 2007 recommended rules, apnea-hypopnea index (AHI) and hypopnea index (HI) increased significantly when the 2007 alternative and 2012 rules were applied (AHI 34.1 ± 13.5/h vs 37.6 ± 13.2/h vs 38.3 ± 13.2/h, respectively; HI 10.2 ± 9.4/h vs 13.7 ± 10.7/h vs 14.4 ± 11.0/h, respectively; all p < 0.001). Duration of CSR increased significantly with the alternate versus recommended 2007 rules (182.2 ± 117.0 vs 170.1 ± 115.0 min; p ≤ 0.001); there was a significant decrease in CSR duration for the 2012 versus 2007 alternative rules (182.2 ± 117.0 vs 166.7 ± 115.4 min; p ≤ 0.001). CONCLUSION: AHI was higher using the AASM 2012 scoring rules due to a less strict definition of hypopnea. Data on the prognostic effects of CSR in patients with HF and the benefits of treatment are mostly based on the AASM 2007 recommended rules, so differences between these and the newer version need to be taken into account.

4 Guideline [ATS clinical policy statement: congenital central hypoventilation syndrome. Genetic basis, diagnosis and management]. 2013

Weese-Mayer, D E / Berry-Kravis, E M / Ceccherini, I / Keens, T G / Loghmanee, D A / Trang, H / Anonymous1020774. · ·Rev Mal Respir · Pubmed #24182656.

ABSTRACT: -- No abstract --

5 Guideline [Which clinical approach and which diagnostic procedures for obstructive sleep apnea syndrome?]. 2010

Escourrou, P / Meslier, N / Raffestin, B / Clavel, R / Gomes, J / Hazouard, E / Paquereau, J / Simon, I / Orvoen Frija, E. ·Laboratoires d'Explorations Fonctionnelles, Hôpital Antoine Béclère, Clamart, France. ·Rev Mal Respir · Pubmed #21129620.

ABSTRACT: -- No abstract --

6 Guideline Best clinical practices for the sleep center adjustment of noninvasive positive pressure ventilation (NPPV) in stable chronic alveolar hypoventilation syndromes. 2010

Berry, Richard B / Chediak, Alejandro / Brown, Lee K / Finder, Jonathan / Gozal, David / Iber, Conrad / Kushida, Clete A / Morgenthaler, Timothy / Rowley, James A / Davidson-Ward, Sally L / Anonymous2840675. ·Division of Pulmonary, Critical Care, and Sleep Medicine, University of Florida, Gainesville, FL 32610-0225, USA. ·J Clin Sleep Med · Pubmed #20957853.

ABSTRACT: Noninvasive positive pressure ventilation (NPPV) devices are used during sleep to treat patients with diurnal chronic alveolar hypoventilation (CAH). Bilevel positive airway pressure (BPAP) using a mask interface is the most commonly used method to provide ventilatory support in these patients. BPAP devices deliver separately adjustable inspiratory positive airway pressure (IPAP) and expiratory positive airway pressure (EPAP). The IPAP and EPAP levels are adjusted to maintain upper airway patency, and the pressure support (PS = IPAP-EPAP) augments ventilation. NPPV devices can be used in the spontaneous mode (the patient cycles the device from EPAP to IPAP), the spontaneous timed (ST) mode (a backup rate is available to deliver IPAP for the set inspiratory time if the patient does not trigger an IPAP/EPAP cycle within a set time window), and the timed (T) mode (inspiratory time and respiratory rate are fxed). During NPPV titration with polysomnography (PSG), the pressure settings, backup rate, and inspiratory time (if applicable) are adjusted to maintain upper airway patency and support ventilation. However, there are no widely available guidelines for the titration of NPPV in the sleep center. A NPPV Titration Task Force of the American Academy of Sleep Medicine reviewed the available literature and developed recommendations based on consensus and published evidence when available. The major recommendations derived by this consensus process are as follows: General Recommendations: 1. The indications, goals of treatment, and side effects of NPPV treatment should be discussed in detail with the patient prior to the NPPV titration study. 2. Careful mask fitting and a period of acclimatization to low pressure prior to the titration should be included as part of the NPPV protocol. 3. NPPV titration with PSG is the recommended method to determine an effective level of nocturnal ventilatory support in patients with CAH. In circumstances in which NPPV treatment is initiated and adjusted empirically in the outpatient setting based on clinical judgment, a PSG should be utilized if possible to confirm that the final NPPV settings are effective or to make adjustments as necessary. 4. NPPV treatment goals should be individualized but typically include prevention of worsening of hypoventilation during sleep, improvement in sleep quality, relief of nocturnal dyspnea, and providing respiratory muscle rest. 5. When OSA coexists with CAH, pressure settings for treatment of OSA may be determined during attended NPPV titration PSG following AASM Clinical Guidelines for the Manual Titration of Positive Airway Pressure in Patients with Obstructive Sleep Apnea. 6. Attended NPPV titration with PSG is the recommended method to identify optimal treatment pressure settings for patients with the obesity hypoventilation syndrome (OHS), CAH due to restrictive chest wall disease (RTCD), and acquired or central CAH syndromes in whom NPPV treatment is indicated. 7. Attended NPPV titration with PSG allows definitive identification of an adequate level of ventilatory support for patients with neuromuscular disease (NMD) in whom NPPV treatment is planned. Recommendations for NPPV Titration Equipment: 1. The NPPV device used for titration should have the capability of operating in the spontaneous, spontaneous timed, and timed mode. 2. The airflow, tidal volume, leak, and delivered pressure signals from the NPPV device should be monitored and recorded if possible. The airflow signal should be used to detect apnea and hypopnea, while the tidal volume signal and respiratory rate are used to assess ventilation. 3. Transcutaneous or end-tidal PCO2 may be used to adjust NPPV settings if adequately calibrated and ideally validated with arterial blood gas testing. 4. An adequate assortment of masks (nasal, oral, and oronasal) in both adult and pediatric sizes (if children are being titrated), a source of supplemental oxygen, and heated humidification should be available. Recommendations for Limits of IPAP, EPAP, and PS Settings: 1. The recommended minimum starting IPAP and EPAP should be 8 cm H2O and 4 cm H2O, respectively. 2. The recommended maximum IPAP should be 30 cm H2O for patients > or = 12 years and 20 cm H2O for patients < 12 years. 3. The recommended minimum and maximum levels of PS are 4 cm H2O and 20 cm H2O, respectively. 4. The minimum and maximum incremental changes in PS should be 1 and 2 cm H2O, respectively. Recommendations for Adjustment of IPAP, EPAP, and PS: 1. IPAP and/or EPAP should be increased as described in AASM Clinical Guidelines for the Manual Titration of Positive Airway Pressure in Patients with Obstructive Sleep Apnea until the following obstructive respiratory events are eliminated (no specific order): apneas, hypopneas, respiratory effort-related arousals, and snoring. 2. The pressure support (PS) should be increased every 5 minutes if the tidal volume is low (< 6 to 8 mL/kg) 3. The PS should be increased if the arterial PCO2 remains 10 mm Hg or more above the PCO, goal at the current settings for 10 minutes or more. An acceptable goal for PCO, is a value less than or equal to the awake PCO2. 4. The PS may be increased if respiratory muscle rest has not been achieved by NPPV treatment at the current settings for 10 minutes of more. 5. The PS may be increased if the SpO, remains below 90% for 5 minutes or more and tidal volume is low (< 6 to 8 mL/kg). Recommendations for Use and Adjustment of the Backup Rate/ Respiratory Rate: 1. A backup rate (i.e., ST mode) should be used in all patients with central hypoventilation, those with a significant number of central apneas or an inappropriately low respiratory rate, and those who unreliably trigger IPAP/EPAP cycles due to muscle weakness. 2. The ST mode may be used if adequate ventilation or adequate respiratory muscle rest is not achieved with the maximum (or maximum tolerated) PS in the spontaneous mode. 3. The starting backup rate should be equal to or slightly less than the spontaneous sleeping respiratory rate (minimum of 10 bpm). 4. The backup rate should be increased in 1 to 2 bpm increments every 10 minutes if the desired goal of the backup rate has not been attained. 5. The IPAP time (inspiratory time) should be set based on the respiratory rate to provide an inspiratory time (IPAP time) between 30% and 40% of the cycle time (60/respiratory rate in breaths per minute). 6. If the spontaneous timed mode is not successful at meeting titration goals then the timed mode can be tried. Recommendations Concerning Supplemental Oxygen: 1. Supplemental oxygen may be added in patients with an awake SpO2 < 88% or when the PS and respiratory rate have been optimized but the SpO2 remains < 90% for 5 minutes or more. 2. The minimum starting supplemental oxygen rate should be 1 L/minute and increased in increments of 1 L/minute about every 5 minutes until an adequate SpO2 is attained (> 90%). Recommendations to Improve Patient Comfort and Patient-NPPV Device Synchrony: 1. If the patient awakens and complains that the IPAP and/or EPAP is too high, pressure should be lowered to a level comfortable enough to allow return to sleep. 2. NPPV device parameters (when available) such as pressure relief, rise time, maximum and minimum IPAP durations should be adjusted for patient comfort and to optimize synchrony between the patient and the NPPV device. 3. During the NPPV titration mask refit, adjustment, or change in mask type should be performed whenever any significant unintentional leak is observed or the patient complains of mask discomfort. If mouth leak is present and is causing significant symptoms (e.g., arousals) use of an oronasal mask or chin strap may be tried. Heated humidification should be added if the patient complains of dryness or significant nasal congestion. Recommendations for Follow-Up: 1. Close follow-up after initiation of NPPV by appropriately trained health care providers is indicated to establish effective utilization patterns, remediate side effects, and assess measures of ventilation and oxygenation to determine if adjustment to NPPV is indicated.

7 Editorial Postconvulsive central apnea and asystole: A risk marker for sudden unexpected death in epilepsy (SUDEP)? 2019

St Louis, Erik K / Dworetzky, Barbara A. ·From the Mayo Center for Sleep Medicine (E.K.S.L.) · Departments of Neurology (E.K.S.L.) and Medicine (E.K.S.L.), Mayo Clinic and Foundation, Rochester, MN · and Department of Neurology (B.A.D.), Brigham and Women's Hospital, Boston, MA. ·Neurology · Pubmed #30568008.

ABSTRACT: -- No abstract --

8 Editorial Treating central sleep apnoea in heart failure: is pull better than push? 2018

Cowie, Martin R / Gallagher, Angela M / Simonds, Anita K. ·National Heart and Lung Institute, Imperial College London (Royal Brompton Hospital), UK. · Sleep & Ventilation Unit, Royal Brompton & Harefield NHS Foundation Trust, London, UK. ·Eur J Heart Fail · Pubmed #30350905.

ABSTRACT: -- No abstract --

9 Editorial Central sleep apnoea in heart failure with reduced ejection fraction, adaptive servo-ventilation, and left ventricular ejection fraction: the (still) missing link. 2018

Ramalho, Sergio H R / Shah, Amil M. ·Division of Cardiovascular Medicine, Brigham and Women's Hospital, Boston, MA, USA. ·Eur J Heart Fail · Pubmed #29271551.

ABSTRACT: -- No abstract --

10 Editorial Pulmonary Hypertension due to Lung Diseases and/or Hypoxia: What Do We Actually Know? 2017

Kosanovic, Djuro / Herrera, Emilio A / Sydykov, Akylbek / Orfanos, Stylianos E / El Agha, Elie. ·Justus-Liebig University, Giessen, Germany. · University of Chile, Santiago, Chile. · National and Kapodistrian University of Athens, Athens, Greece. ·Can Respir J · Pubmed #28932130.

ABSTRACT: -- No abstract --

11 Editorial Ambulatory Apnea Monitoring in Heart Failure: Proceed With Caution. 2017

Floras, John S. ·University Health Network and Sinai Health System Division of Cardiology, University of Toronto, Toronto, Ontario, Canada. Electronic address: john.floras@utoronto.ca. ·J Am Coll Cardiol · Pubmed #28882234.

ABSTRACT: -- No abstract --

12 Editorial SERVE-HF on-treatment analysis: does the on-treatment analysis SERVE its purpose? 2017

Bradley, T Douglas. ·Dept of Medicine, University of Toronto, Toronto, ON, Canada douglas.bradley@utoronto.ca. · Sleep Research Laboratories, University Health Network Toronto Rehabilitation Institute and Toronto General Hospital, Toronto, ON, Canada. ·Eur Respir J · Pubmed #28860273.

ABSTRACT: -- No abstract --

13 Editorial Withdrawing ASV therapy in clinical practice: trials and tribulations. 2017

Cowie, Martin R. ·Imperial College London (Royal Brompton Hospital), United Kingdom. Electronic address: m.cowie@imperial.ac.uk. ·Sleep Med · Pubmed #28366779.

ABSTRACT: -- No abstract --

14 Editorial Central Sleep Apnea in Heart Failure: Sleeping With the Wrong Enemy? 2017

Fang, James C / Vidic, Andrija. ·University of Utah, Salt Lake City, Utah. Electronic address: james.fang@hsc.utah.edu. · University of Utah, Salt Lake City, Utah. ·J Am Coll Cardiol · Pubmed #28335842.

ABSTRACT: -- No abstract --

15 Editorial Central sleep apnea: the problem of diagnosis. 2017

Randerath, W. ·University of Cologne, Clinic for Pneumology and Allergology, Centre of Sleep Medicine and Respiratory Care, Bethanien Hospital, Aufderhöherstraße 169-175, 42699, Solingen, Germany. Electronic address: randerath@klinik-bethanien.de. ·Sleep Med · Pubmed #28153696.

ABSTRACT: -- No abstract --

16 Editorial CSA Is Not Beneficial Long Term in Heart Failure Patients with Reduced Ejection Fraction. 2017

Oldenburg, Olaf / Coats, Andrew. ·Clinic for Cardiology, Herz- und Diabeteszentrum NRW, Ruhr-Universität Bochum, Bad Oeynhausen, Germany. Electronic address: akleemeyer@hdz-nrw.de. · Monash University, Australia and University of Warwick, UK. ·Int J Cardiol · Pubmed #27825728.

ABSTRACT: Central sleep apnea (CSA) affects many patients, with heart failure and results in hypoxia and nor-epinephrine release and is associated with high morbidity and mortality. Recent trials in the treatment of CSA using positive airway pressure therapies have failed to demonstrate improvement in mortality and as a result, the compensatory nature of CSA has been questioned. The detrimental effects from CSA are clear. While there may be a short term compensatory effect, the long term effects cause chronic insult to the cardiovascular system indicating that CSA should be treated, but alternative treatment options need to be considered.

17 Editorial Sympathetic nervous system, systolic heart failure, and central sleep apnea: Are we about to find the missing link? 2017

Lairez, Olivier / Legallois, Damien / Agostini, Denis. ·Département de Médecine Nucléaire, CHU Rangueil, Toulouse, France. · Service de Cardiologie, CHU Côte de Nacre, Caen, France. · Service de Médecine Nucléaire, CHU Côte de Nacre, Caen, France. · Service de Médecine Nucléaire, CHU Côte de Nacre, Caen, France. Agostini-de@chu-caen.fr. ·J Nucl Cardiol · Pubmed #27457530.

ABSTRACT: -- No abstract --

18 Editorial Central sleep apnoea: to treat or not to treat? 2016

Cowie, Martin R. ·National Heart and Lung Institute, Imperial College London, Royal Brompton Hospital, London, UK. m.cowie@imperial.ac.uk. ·Eur J Heart Fail · Pubmed #27634624.

ABSTRACT: -- No abstract --

19 Editorial Does Age Matter? The Relationship between Sleep-disordered Breathing and Incident Atrial Fibrillation in Older Men. 2016

Morrell, Mary J / McMillan, Alison. ·1 National Heart and Lung Institute Imperial College London London, United Kingdom. ·Am J Respir Crit Care Med · Pubmed #27035781.

ABSTRACT: -- No abstract --

20 Editorial Central sleep apnoea in heart failure--An important issue for the modern heart failure cardiologist. 2016

Coats, Andrew J Stewart / Abraham, William T. ·Monash University, Australia; University of Warwick, Coventry, UK. Electronic address: ajscoats@aol.com. · Ohio State University, Columbus, OH, USA. ·Int J Cardiol · Pubmed #26971184.

ABSTRACT: -- No abstract --

21 Editorial Heart Failure and Sleep-disordered Breathing. The Chicken or the Egg? 2016

Naughton, Matthew T. ·1 Department of Allergy, Immunology, and Respiratory Medicine The Alfred Hospital Melbourne, Victoria, Australia and. · 2 Monash University Melbourne, Victoria, Australia. ·Am J Respir Crit Care Med · Pubmed #26930431.

ABSTRACT: -- No abstract --

22 Editorial Adaptive Servo-ventilation and the Treatment of Central Sleep Apnea in Heart Failure. Let's Not Throw the Baby Out with the Bathwater. 2016

Bradley, T Douglas / Floras, John S. ·1 Sleep Research Laboratory of the University Health Network Toronto Rehabilitation Institute Toronto, Ontario, Canada. · 2 Department of Medicine University Health Network Toronto, Ontario, Canada and. · 3 Department of Medicine University of Toronto Toronto, Ontario, Canada. · 4 Department of Medicine Mount Sinai Hospital Toronto, Ontario, Canada and. · 5 Peter Munk Cardiac Centre University Health Network Toronto, Ontario, Canada. ·Am J Respir Crit Care Med · Pubmed #26646208.

ABSTRACT: -- No abstract --

23 Editorial SERVE-HF: What does it mean for cardiac rehabilitation? 2016

Skobel, Erik C / Krüger, Stefan. ·Clinic for Cardiac and Pulmonary Rehabilitation, Aachen, Germany erik.skobel@online.de. · Klinik für Pneumologie, Kardiologie und Internistische Intensivmedizin, Florence Nightingale Krankenhaus, Germany Klinik für Kardiologie, Pneumologie und Angiologie, Universitätsklinikum Düsseldorf, Germany. ·Eur J Prev Cardiol · Pubmed #26635359.

ABSTRACT: -- No abstract --

24 Editorial Sleep-disordered breathing and chronic heart failure: changing position may be important. 2015

van der Wal, Haye H / Cowie, Martin R / van der Meer, Peter. ·Department of Cardiology, University Medical Centre Groningen, University of Groningen, Groningen, the Netherlands. · Imperial College London (Royal Brompton Hospital), London, United Kingdom. ·Eur J Heart Fail · Pubmed #26647215.

ABSTRACT: -- No abstract --

25 Editorial Adaptive Servoventilation: Answer to a Sleep Physician's Dream? 2015

Brown, Lee K. ·Division of Pulmonary, Critical Care, and Sleep Medicine, Department of Internal Medicine, School of Medicine, and the Department of Electrical and Computer Engineering, School of Engineering, University of New Mexico, Albuquerque, NM. Electronic address: lkbrown@alum.mit.edu. ·Chest · Pubmed #26621290.

ABSTRACT: -- No abstract --